Transgene Market Cap

Transgene has a market cap or net worth of €92.92 million as of January 17, 2025. Its market cap has decreased by -32.16% in one year.

Market Cap

92.92M

Enterprise Value

114.38M

Revenue

6.49M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.71

Market Cap Chart

Since March 30, 1998, Transgene's market cap has decreased from 151.86M to 92.92M, a decrease of -38.81%. That is a compound annual growth rate of -1.81%.

Market Cap History

Date	Market Cap	% Change
Jan 20, 2025	92.92M	3.53%
Dec 31, 2024	89.75M	-34.86%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	137.90M	6.95%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sanofi	122.52B
EssilorLuxottica Société anonyme	111.25B
Sartorius Stedim Biotech	19.17B
bioMérieux	13.05B
Ipsen	10.15B
Eurofins Scientific SE	8.85B
Virbac	2.58B
Ramsay Générale de Santé	1.35B

Market Cap Rankings